Citadel Advisors
EVGN icon

Citadel Advisors’s Evogene EVGN Stock Holding History

Citadel Advisors’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4K Buy
+50,526
New +$35K ﹤0.01% 13393
2026
Q1 		– Sell
-88,764
Closed -$97.6K – 13300
2025
Q4 		$97.6K Buy
88,764
+31,189
+54% +$36.4K ﹤0.01% 11662
2025
Q3 		$65.6K Buy
57,575
+36,206
+169% +$45.8K ﹤0.01% 12067
2025
Q2 		$27.4K Buy
+21,369
New +$26.1K ﹤0.01% 12018
2025
Q1 		– Sell
-15,891
Closed -$29.7K – 14753
2024
Q4 		$29.7K Buy
+15,891
New +$31.3K ﹤0.01% 12885
2024
Q3 		– Sell
-2,371
Closed -$15.4K – 14481
2024
Q2 		$15.4K Sell
2,371
-3,620
-60% -$25.3K ﹤0.01% 12832
2024
Q1 		$44.3K Buy
5,991
+319
+6% +$2.66K ﹤0.01% 12290
2023
Q4 		$47.6K Buy
5,672
+2,923
+106% +$18.4K ﹤0.01% 11831
2023
Q3 		$16.1K Buy
2,749
+1,539
+127% +$13.5K ﹤0.01% 12789
2023
Q2 		$12.9K Sell
1,210
-4,483
-79% -$30.3K ﹤0.01% 13060
2023
Q1 		$35.9K Sell
5,693
-2,760
-33% -$20.5K ﹤0.01% 12560
2022
Q4 		$59.2K Sell
8,453
-1,217
-13% -$8.58K ﹤0.01% 11924
2022
Q3 		$80K Buy
+9,670
New +$93.2K ﹤0.01% 11282
2022
Q2 		– Sell
-1,524
Closed -$14.9K – 13169
2022
Q1 		$20K Sell
1,524
-8,546
-85% -$115K ﹤0.01% 13237
2021
Q4 		$165K Buy
10,070
+2,534
+34% +$57.5K ﹤0.01% 12139
2021
Q3 		$199K Sell
7,536
-3,825
-34% -$112K ﹤0.01% 11986
2021
Q2 		$388K Sell
11,361
-3,915
-26% -$153K ﹤0.01% 10644
2021
Q1 		$770K Buy
+15,276
New +$945K ﹤0.01% 8731
2019
Q4 		– Sell
-1,938
Closed -$31K – 9271
2019
Q3 		$31K Buy
+1,938
New +$30.5K ﹤0.01% 8839
2019
Q1 		– Sell
-1,385
Closed -$28K – 9420
2018
Q4 		$28K Buy
+1,385
New +$35K ﹤0.01% 8638

Other funds holding EVGN

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM

Citadel Advisors's EVGN Position: Q2 2026 in Review

Citadel Advisors opened a new position in Evogene (EVGN) in Q2 2026: 50,526 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #13393 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in EVGN as recently as Q4 2025.

Citadel Advisors first reported a position in EVGN in Q4 2018 and has held it in 20 quarters since. The position peaked at $770K in Q1 2021. 13 funds tracked by Wall St. Rank hold EVGN as of Q2 2026.

  • Citadel Advisors held 50,526 shares of Evogene worth $21.4K as of Q2 2026.
  • Evogene was a new Citadel Advisors position in Q2 2026.
  • Evogene made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13393 holding.
  • Citadel Advisors first reported a position in Evogene in Q4 2018 and has held it in 20 quarters since.
  • Citadel Advisors's Evogene position peaked at $770K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.